ONT.L
Oxford Nanopore Technologies develops nanopore sequencing devices and accompanying analysis tools for real-time, long-read genomic sequencing. The company offers portable and high-throughput sequencing solutions aimed at research and clinical applications, spanning human, microbial, plant, environmental, and cancer genomics. Headquartered in the UK, it operates globally with devices like MinION, GridION, and PromethION, and provides resources, training, and support for researchers across multiple disciplines.
No recent deals for this company.